KeyBank National Association
DXCM icon

KeyBank National Association’s DexCom DXCM Stock Holding History

KeyBank National Association’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
8,363
-379
-4% -$25.3K ﹤0.01% 870
2026
Q1 		$549K Buy
8,742
+1,154
+15% +$80.4K ﹤0.01% 791
2025
Q4 		$504K Sell
7,588
-440
-5% -$28.4K ﹤0.01% 805
2025
Q3 		$540K Sell
8,028
-8,138
-50% -$644K ﹤0.01% 760
2025
Q2 		$1.41M Sell
16,166
-1,167
-7% -$91.5K 0.01% 500
2025
Q1 		$1.18M Sell
17,333
-252
-1% -$20.6K ﹤0.01% 519
2024
Q4 		$1.37M Buy
17,585
+8,853
+101% +$655K 0.01% 488
2024
Q3 		$585K Sell
8,732
-2,179
-20% -$179K ﹤0.01% 717
2024
Q2 		$1.24M Buy
10,911
+1,933
+22% +$244K 0.01% 483
2024
Q1 		$1.25M Buy
8,978
+5,788
+181% +$728K 0.01% 482
2023
Q4 		$396K Buy
3,190
+187
+6% +$19.1K ﹤0.01% 839
2023
Q3 		$280K Sell
3,003
-1,681
-36% -$189K ﹤0.01% 884
2023
Q2 		$602K Buy
4,684
+1,688
+56% +$204K ﹤0.01% 642
2023
Q1 		$348K Sell
2,996
-96
-3% -$10.7K ﹤0.01% 840
2022
Q4 		$350K Sell
3,092
-261
-8% -$28.7K ﹤0.01% 820
2022
Q3 		$270K Sell
3,353
-703
-17% -$59.5K ﹤0.01% 887
2022
Q2 		$302K Buy
4,056
+1,208
+42% +$110K ﹤0.01% 873
2022
Q1 		$364K Sell
2,848
-2,268
-44% -$248K ﹤0.01% 846
2021
Q4 		$687K Sell
5,116
-1,124
-18% -$162K ﹤0.01% 710
2021
Q3 		$853K Sell
6,240
-244
-4% -$30.8K ﹤0.01% 622
2021
Q2 		$692K Sell
6,484
-724
-10% -$69.5K ﹤0.01% 697
2021
Q1 		$648K Buy
7,208
+24
+0.3% +$2.25K ﹤0.01% 732
2020
Q4 		$664K Buy
7,184
+3,668
+104% +$328K ﹤0.01% 671
2020
Q3 		$362K Buy
3,516
+116
+3% +$12.1K ﹤0.01% 787
2020
Q2 		$345K Buy
3,400
+324
+11% +$29K ﹤0.01% 778
2020
Q1 		$207K Buy
+3,076
New +$191K ﹤0.01% 853

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

KeyBank National Association's DXCM Position: Q2 2026 in Review

KeyBank National Association reduced its DexCom (DXCM) stake by 4.3% in Q2 2026, selling an estimated $25.3K and leaving 8,363 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

KeyBank National Association first reported a position in DXCM in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.41M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • KeyBank National Association held 8,363 shares of DexCom worth $563K as of Q2 2026.
  • KeyBank National Association sold 379 DexCom shares in Q2 2026, an estimated $25.3K.
  • DexCom made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #870 holding.
  • KeyBank National Association first reported a position in DexCom in Q1 2020 and has held it in 26 quarters since.
  • KeyBank National Association's DexCom position peaked at $1.41M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.